Literature DB >> 30666964

Coronary chronic total occlusions and mortality in patients with ventricular tachyarrhythmias.

Michael Behnes1, Ibrahim Akin, Philipp Kuche, Tobias Schupp, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Ibrahim El-Battrawy, Siegfried Lang, Emmanouil S Brilakis, Lorenzo Azzalini, Alfredo R Galassi, Marouane Boukhris, Hans Neuser, Franz-Joseph Neumann, Christoph Nienaber, Christel Weiß, Martin Borggrefe, Kambis Mashayekhi.   

Abstract

AIMS: This study sought to assess the prognostic impact of coronary chronic total occlusions (CTO) in patients presenting with ventricular tachyarrhythmias on admission. METHODS AND
RESULTS: A large retrospective registry was used, including all consecutive patients presenting with ventricular tachyarrhythmias on admission and undergoing coronary angiography from 2002 to 2016. Patients with a CTO were compared with all other patients (non-CTO) for prognostic outcomes. Statistics comprised Kaplan-Meier and Cox regression analyses. Within a total of 1,461 consecutive patients included with ventricular tachyarrhythmias on admission, a CTO was present in 20%. At midterm follow-up of 18 months, the primary endpoint all-cause mortality had occurred in 40% of CTO patients compared to 27% of non-CTO patients (HR 1.563, 95% CI: 1.263-1.934; p=0.001). The rates of secondary endpoints were higher for in-hospital all-cause mortality at index (29% versus 20%, log-rank p=0.027) and the composite endpoint of cardiac death at 24 hours, recurrent ventricular tachyarrhythmias and appropriate ICD therapies at midterm follow-up (28% versus 20%, log-rank p=0.005). Mortality rates were highest in CTO patients with stable coronary artery disease (CAD), acute myocardial infarction and in patients surviving index hospitalisation.
CONCLUSIONS: In patients presenting with ventricular tachyarrhythmias on admission, the presence of a coronary CTO is independently associated with an increase of midterm all-cause mortality, in-hospital all-cause mortality and the composite endpoint of early cardiac death, recurrent ventricular tachyarrhythmias and appropriate ICD therapies.

Entities:  

Mesh:

Year:  2020        PMID: 30666964     DOI: 10.4244/EIJ-D-18-00496

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Switching From Proximal to Distal Radial Artery Access for Coronary Chronic Total Occlusion Recanalization.

Authors:  Alexandru Achim; Tímea Szigethy; Dorottya Olajos; Levente Molnár; Roland Papp; György Bárczi; Kornél Kákonyi; István F Édes; Dávid Becker; Béla Merkely; Jef Van den Eynde; Zoltán Ruzsa
Journal:  Front Cardiovasc Med       Date:  2022-05-09

2.  Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias.

Authors:  Ibrahim Akin; Michael Behnes; Julian Müller; Jan Forner; Mohammad Abumayyaleh; Kambis Mashayekhi; Muharrem Akin; Thomas Bertsch; Kathrin Weidner; Jonas Rusnak; Dirk Große Meininghaus; Maximilian Kittel; Tobias Schupp
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

3.  Special Issue: Sudden Cardiac Death: Clinical Updates and Perspectives.

Authors:  Tobias Schupp; Ibrahim Akin; Michael Behnes
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

4.  Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study.

Authors:  Taek Kyu Park; Seung Hun Lee; Ki Hong Choi; Joo Myung Lee; Jeong Hoon Yang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Hyeon-Cheol Gwon; Sang Hoon Lee; Seung-Hyuk Choi
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

5.  Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias.

Authors:  Michael Behnes; Jonas Rusnak; Gabriel Taton; Tobias Schupp; Linda Reiser; Armin Bollow; Thomas Reichelt; Niko Engelke; Dominik Ellguth; Philipp Kuche; Siegfried Lang; Christoph A Nienaber; Kambis Mashayekhi; Muharrem Akin; Thomas Bertsch; Dennis Ferdinand; Christel Weiss; Martin Borggrefe; Ibrahim Akin
Journal:  Sci Rep       Date:  2019-10-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.